Clinical Study Results
Did any adverse reactions happen during this study?
There were 18.8% of participants who had adverse reactions during the study that the study doctors thought might be related to savolitinib. This was 3 out of 16 participants.
None of the participants had adverse reactions during the study that the study doctors thought might be related to famotidine.
None of the participants left the study due to adverse reactions.
What serious adverse reactions happened during this study?
None of the participants had serious adverse reactions during this study.
None of the participants died due to serious adverse reactions during this study.
What adverse reactions happened during this study?
There were 2 different adverse reactions that happened during this study. The study doctors thought that each adverse reaction might be related to savolitinib:
- A small increase in transaminase levels in the blood, which is a sign of possible liver damage, happened in 12.5% of participants. This was 2 out of 16 participants. By the end of the study, the transaminase levels in these participants returned to normal.
- Headache happened in 6.3% of participants. This was 1 out of 16 participants.